Fresenius Ventures

Fresenius Ventures is the venture capital arm of Fresenius, a global healthcare leader serving 450 million people annually. The firm invests from Series A through growth stages in life‑science and healthcare startups that aim to transform patient care, medical outcomes, and health‑system efficiency. Backed by the broader Fresenius ecosystem, it provides €5‑15 million per deal plus deep clinical, regulatory, manufacturing, and market‑access expertise, as well as strategic M&A opportunities within the Fresenius network. Focus areas include pharma, med‑tech, and care‑provision technologies with strong scientific validation, defensible IP, and visionary founders. Operating globally, Fresenius Ventures partners with innovators to accelerate and scale frontier healthcare solutions that are more effective, accessible, and affordable.